Diakonos Oncology (Private Placement)
Funding Details
- Awarder
- RSS - feeds.feedburner.com
- Date Award
- May 31, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $20,000,000
Company Info
- Traction
- The company is accelerating its Phase 2 glioblastoma trial and has previously closed an oversubscribed $11.4 million seed financing.
- Founders
- Mike Wicks
- Company Description
- Diakonos Oncology is a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers.
- Market
- Immunotherapy for aggressive cancers
- Location
- Houston, Texas, USA
- Coinvestors
- Baylor College of Medicine, Brain Tumor Investment Fund, Buttonwood Titan QC Fund